151 related articles for article (PubMed ID: 21366040)
21. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
[TBL] [Abstract][Full Text] [Related]
22. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
23. Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
Jackson T; Woo LW; Trusselle MN; Chander SK; Purohit A; Reed MJ; Potter BV
Org Biomol Chem; 2007 Sep; 5(18):2940-52. PubMed ID: 17728860
[TBL] [Abstract][Full Text] [Related]
24. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Nagar S; Saha A
Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757
[TBL] [Abstract][Full Text] [Related]
25. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
26. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV
J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272
[TBL] [Abstract][Full Text] [Related]
27. Synthetic isoflavones and doping: A novel class of aromatase inhibitors?
Iannone M; Botrè F; Cardillo N; de la Torre X
Drug Test Anal; 2019 Feb; 11(2):208-214. PubMed ID: 30118172
[TBL] [Abstract][Full Text] [Related]
28. Hybrid flavan-chalcones, aromatase and lipoxygenase inhibitors, from Desmos cochinchinensis.
Bajgai SP; Prachyawarakorn V; Mahidol C; Ruchirawat S; Kittakoop P
Phytochemistry; 2011 Nov; 72(16):2062-7. PubMed ID: 21802698
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling.
Jackson T; Woo LW; Trusselle MN; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Apr; 3(4):603-18. PubMed ID: 18236493
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis of chrysin derivatives and their interaction with DNA].
Zhang ZT; Chen LL
Yao Xue Xue Bao; 2007 May; 42(5):492-6. PubMed ID: 17703770
[TBL] [Abstract][Full Text] [Related]
31. Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
Woo LW; Jackson T; Putey A; Cozier G; Leonard P; Acharya KR; Chander SK; Purohit A; Reed MJ; Potter BV
J Med Chem; 2010 Mar; 53(5):2155-70. PubMed ID: 20148564
[TBL] [Abstract][Full Text] [Related]
32. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells.
Edmunds KM; Holloway AC; Crankshaw DJ; Agarwal SK; Foster WG
Reprod Nutr Dev; 2005; 45(6):709-20. PubMed ID: 16285913
[TBL] [Abstract][Full Text] [Related]
33. Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions.
Seo JI; Yu JS; Zhang Y; Yoo HH
Chem Biol Interact; 2024 Apr; 392():110927. PubMed ID: 38403145
[TBL] [Abstract][Full Text] [Related]
34. Steroidal carbonitriles as potential aromatase inhibitors.
Yadav MR; Sabale PM; Giridhar R; Zimmer C; Hartmann RW
Steroids; 2012 Jul; 77(8-9):850-7. PubMed ID: 22546985
[TBL] [Abstract][Full Text] [Related]
35. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
37. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of some novel androstanes as potential aromatase inhibitors.
Yadav MR; Sabale PM; Giridhar R; Zimmer C; Haupenthal J; Hartmann RW
Steroids; 2011 Apr; 76(5):464-70. PubMed ID: 21215765
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the mutagenic activity of chrysin, a flavonoid inhibitor of the aromatization process.
Oliveira GA; Ferraz ER; Souza AO; Lourenço RA; Oliveira DP; Dorta DJ
J Toxicol Environ Health A; 2012; 75(16-17):1000-11. PubMed ID: 22852850
[TBL] [Abstract][Full Text] [Related]
40. Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship Perspective.
Shah U; Patel A; Patel S; Patel M; Patel A; Patel S; Patel S; Maheshwari R; Mtewa AG; Gandhi K
Anticancer Agents Med Chem; 2022; 22(11):2063-2079. PubMed ID: 34702156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
